bn:17457551n
Noun Concept
AR
No term available
EN
Empagliflozin/linagliptin, sold under the brand name Glyxambi, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. Wikipedia
Relations
Sources